Literature DB >> 22648936

Hereditary pheochromocytoma and paraganglioma.

Peter J Mazzaglia1.   

Abstract

Hereditary pheochromocytomas (pheo) and paragangliomas (pgl) are caused by identifiable germline mutations. The previously well-known associated syndromes include neurofibromatosis type 1, multiple endocrine neoplasia 2 A and B, and von Hippel-Lindau syndrome. Newly discovered mutations in the succinate dehydrogenase gene complex have been identified as a cause of inherited pgls and pheos. It is now clear that up to 30% of patients presenting with sporadic pheos/pgls harbor a recognizable germline mutation, and therefore directed genetic testing is recommended for many of these patients.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22648936     DOI: 10.1002/jso.23157

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  8 in total

1.  Familial paraganglioma syndrome: a rare cause of carotid artery occlusion.

Authors:  Francesca Rosafio; Maria Luisa Dell'Acqua; Bruno Madeo; Elda Kara; Laura Vandelli; Stefano Vallone; Guido Bigliardi; Livio Picchetto; Paolo Nichelli; Andrea Zini
Journal:  J Neurol       Date:  2016-10-20       Impact factor: 4.849

2.  Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors.

Authors:  Bruna Babic; Dhaval Patel; Rachel Aufforth; Yasmine Assadipour; Samira M Sadowski; Martha Quezado; Naris Nilubol; Tamara Prodanov; Karel Pacak; Electron Kebebew
Journal:  Surgery       Date:  2016-11-16       Impact factor: 3.982

3.  A 15-year-old girl with a parotid mass and hypertension: Answers.

Authors:  Philip K Angelides; Clement D Lee; Stephanie Clark
Journal:  Pediatr Nephrol       Date:  2022-05-18       Impact factor: 3.651

Review 4.  Pheochromocytoma and paraganglioma-an update on diagnosis, evaluation, and management.

Authors:  Amrish Jain; Rossana Baracco; Gaurav Kapur
Journal:  Pediatr Nephrol       Date:  2019-01-02       Impact factor: 3.714

Review 5.  When should genetic testing be performed in patients with neuroendocrine tumours?

Authors:  Triona O'Shea; Maralyn Druce
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

Review 6.  Haemorrhagic retroperitoneal paraganglioma initially manifesting as acute abdomen: a rare case report and literature review.

Authors:  Yanliang Yang; Guangzhi Wang; Haofeng Lu; Yaqing Liu; Shili Ning; Fuwen Luo
Journal:  BMC Surg       Date:  2020-11-30       Impact factor: 2.102

7.  Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort.

Authors:  Judit Dénes; Francesca Swords; Eleanor Rattenberry; Karen Stals; Martina Owens; Treena Cranston; Paraskevi Xekouki; Linda Moran; Ajith Kumar; Christopher Wassif; Naomi Fersht; Stephanie E Baldeweg; Damian Morris; Stafford Lightman; Amar Agha; Aled Rees; Joan Grieve; Michael Powell; Cesar Luiz Boguszewski; Pinaki Dutta; Rajesh V Thakker; Umasuthan Srirangalingam; Chris J Thompson; Maralyn Druce; Claire Higham; Julian Davis; Rosalind Eeles; Mark Stevenson; Brendan O'Sullivan; Phillipe Taniere; Kassiani Skordilis; Plamena Gabrovska; Anne Barlier; Susan M Webb; Anna Aulinas; William M Drake; John S Bevan; Cristina Preda; Nadezhda Dalantaeva; Antônio Ribeiro-Oliveira; Isabel Tena Garcia; Galina Yordanova; Violeta Iotova; Jane Evanson; Ashley B Grossman; Jacqueline Trouillas; Sian Ellard; Constantine A Stratakis; Eamonn R Maher; Federico Roncaroli; Márta Korbonits
Journal:  J Clin Endocrinol Metab       Date:  2014-12-12       Impact factor: 5.958

8.  Pheochromocytoma in a Twelve-Year-Old Girl with SDHB-Related Hereditary Paraganglioma-Pheochromocytoma Syndrome.

Authors:  Daryl Graham; Megan Gooch; Zhan Ye; Edward Richer; Aftab Chishti; Elizabeth Reilly; John D'Orazio
Journal:  Case Rep Genet       Date:  2014-08-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.